SpaceX’s $8 billion spectrum deal gave Wall Street its most violent single-day sector reshuffle of the year on Friday: T-Mobile lost 13.3%, AT&T lost 9.8%, and Crown Castle jumped nearly 16%. Humana surged almost 12% on better Medicare ratings, and Delta cut its profit outlook on fuel costs. Those stories set up the stocks to watch tomorrow, Monday, October 12, a session where U.S. stocks trade but banks and bond markets are closed for the holiday.
Stocks to Watch Tomorrow: Friday’s Market Snapshot
| Metric | Friday Close / Reading |
|---|---|
| S&P 500 | 7,811.54 (+0.59%); +1.2% on the week |
| Dow Jones Industrial Average | 51,654.95 (+0.83%); +0.9% on the week |
| Nasdaq Composite | 27,366.17 (+0.64%); +0.6% on the week |
| Russell 2000 | 2,806.98 (+0.46%); -0.9% on the week |
| 10-Year Treasury Yield | 5.24% |
| VIX | 14.84 |
| WTI Crude | $91.62 |
| Gold | ~$4,216 |
U.S. stocks closed out a record-setting week as the S&P 500 finished just shy of its all-time high. Oil steadied after Trump said the U.S. would not strike Iran before the midterms, and FactSet’s third-quarter S&P 500 earnings growth estimate sits near 29.6%.
The week ahead: Monday has no major earnings, and the bank and bond markets are closed. JPMorgan, Goldman Sachs, Citigroup, Wells Fargo, UnitedHealth and Johnson & Johnson report Tuesday. September CPI is due Wednesday, with consensus at 3.6%, up from 3.4%.
Data note: Closes are Friday, October 9 figures where a source published one. For names without a confirmed close we show the latest midday or after-hours print and say so. Derived figures are labeled. Support and resistance levels are analytical zones, not guaranteed targets.
1. T-Mobile US (TMUS) | Last Close $148.58 (-13.27%) | Worst Day Since 2013
SpaceX Just Became a Fourth Carrier Candidate, and $39 Billion Vanished
T-Mobile fell 13.27% to $148.58, its worst day since 2013, after SpaceX agreed to buy a nationwide 800 MHz spectrum portfolio from Grain Management.
| Metric | Value |
|---|---|
| Last Close | $148.58 (Oct 9) |
| Previous Close | ~$171.31 (Oct 8; derived) |
| Day’s Move | -13.27% (about -$22.73) |
| Day’s Range | Not confirmed |
| 52-Week Range | Not confirmed |
| Market Cap | Not confirmed (carriers shed ~$39B combined at the open) |
| P/E / Dividend | Not confirmed / Pays a dividend |
| Volume vs. Average | Not confirmed (AT&T traded at ~2.8x average) |
| Trend | Broke support, per FX Leaders |
| Analyst View | Bernstein: a fourth player is “still a net negative” |
| Support 1 / 2 / 3 | ~$145 / ~$140 / ~$130 |
| Resistance 1 / 2 / 3 | ~$155 / ~$160 / ~$171.31 |
Catalyst & Latest News: The deal is subject to FCC approval, and FCC Chair Brendan Carr said competition in spectrum is good news for consumers. Evercore says SpaceX “now has the outline of a real network.”
Technicals: A gap this large usually leaves a weak first bounce. $171 is the gap’s upper edge.
Fundamentals: Last week T-Mobile, AT&T and Verizon formed a joint venture to expand satellite coverage without Starlink, so the rivalry was already building.
Bull Case: FCC approval is not guaranteed, SpaceX still needs ground towers, and the sell-off may be overdone. Bear Case: A well-funded fourth competitor changes pricing power for the whole group.
What to Watch:
- Whether $145 holds
- Analyst target cuts
- FCC filings on the Grain transfer
Forecast: A bounce toward $155 is possible, but a close under $145 points to $140.
Why This Matters: TMUS is the center of the spectrum shock and the cleanest read on investor fear of Starlink Mobile.
2. AT&T (T) | Last Close $22.17 (-9.81%) | 140 Million Shares in a Worst-Day-Since-2000 Slide
Volume Hit 182% Above Average as Telecom Support Cracked
AT&T closed at $22.17, down 9.81%, on volume of 140.3 million shares versus a 49.8 million three-month average. Verizon fell 8.75% to $41.65, its worst day since 2002.
| Metric | Value |
|---|---|
| Last Close | $22.17 (Oct 9) |
| Previous Close | ~$24.58 (Oct 8; derived) |
| Day’s Move | -9.81% (about -$2.41) |
| Day’s Range | Not confirmed |
| 52-Week Range | Not confirmed |
| Market Cap | Not confirmed |
| P/E / Dividend | Not confirmed / Pays a dividend |
| Volume vs. Average | 140.3M vs. 49.8M (+182%) |
| Peer Move | Verizon -8.75% to $41.65; T-Mobile -13.27% |
| Analyst View | Investors watching Q3 earnings for guidance |
| Support 1 / 2 / 3 | ~$22 / ~$21 / ~$20 |
| Resistance 1 / 2 / 3 | ~$23 / ~$24 / ~$24.58 |
Catalyst & Latest News: Benzinga reports the three carriers shed about $39 billion in value, roughly five times what SpaceX paid for the spectrum.
Technicals: A heavy-volume breakdown through round-number support. The gap to $24.58 is the first resistance.
Fundamentals: The investment case rests on a stable three-player market, which the news questioned.
Bull Case: Regulatory approval and ground-network costs could delay SpaceX. Bear Case: Pricing pressure and subscriber losses if Starlink Mobile scales.
What to Watch:
- A hold above $22
- Q3 earnings guidance
- Dividend-safety commentary
Forecast: Failure at $22 opens $21 and $20. A rebound needs a close over $23.
Why This Matters: T and VZ show the dividend-defensive group trading like it has lost its moat.
3. Crown Castle (CCI) | Last Close ~$79.64 (+15.6%) | The Tower Landlord Wins a New Tenant Theory
From 52-Week Lows to a 16% Day on SpaceX’s Ground-Network Need
Crown Castle rose about 15.6% to $79.64 as investors bet SpaceX would need thousands of tower sites for Starlink Mobile. American Tower gained about 9%.
| Metric | Value |
|---|---|
| Last Close | ~$79.64 (Oct 9) |
| Previous Close | ~$68.9 (Oct 8; derived) |
| Day’s Move | +15.6% (intraday high near +16%) |
| Day’s Range | Not confirmed |
| 52-Week Range | Low near $69 (set before Friday); high near $105 (as of August data) |
| Market Cap | ~$34.8B (derived from ~436M shares) |
| P/E / Dividend | Not confirmed / $4.25 per year (~5.3% at $79.64) |
| Volume vs. Average | Not confirmed (30-day average ~4.5M) |
| Analyst View | Consensus target near $99 (earlier data) |
| Support 1 / 2 / 3 | ~$76 / ~$72 / ~$69 |
| Resistance 1 / 2 / 3 | ~$82 / ~$88.66 / ~$99 |
Catalyst & Latest News: Crown Castle had no company-specific announcement. BigGo Finance notes it is now a pure-play tower operator after divesting fiber and small cells, so a new tenant could add revenue without extra capital spending.
Technicals: The stock had been near its lows. A close above the $76 area would confirm a base, and $88.66 is the price of its completed buyback.
Fundamentals: Next earnings are estimated for October 21. Management raised 2026 guidance in the prior quarter.
Bull Case: A new anchor tenant theory, a 5%-plus yield and a washed-out chart. Bear Case: SpaceX is a speculative tenant, the deal needs FCC approval, and the gain is a one-day repricing.
What to Watch:
- A hold above $76
- Tower-lease commentary from SpaceX
- The October 21 report
Forecast: Holding $76 targets $82, then $88.66. Under $76, the move likely fades.
Why This Matters: CCI is the “picks and shovels” winner of a carrier shake-up.
4. SpaceX (SPCX) | Last Close $162.57 (+1.25%) | A $2.1 Trillion Company Buys the Missing Spectrum
Up 1.25% After a 4.19% Slide, With Barclays Initiating at $254
SpaceX closed at $162.57, up $2.00, after falling 4.19% Thursday to $160.57 when the deal was announced.
| Metric | Value |
|---|---|
| Last Close | $162.57 (after-hours $162.76) |
| Previous Close | $160.57 (Oct 8, -4.19%) |
| Day’s Move | +1.25% (+$2.00) |
| Day’s Range | $160.61 – $166.38 (open $165.34) |
| 52-Week Range | $104.83 (Aug 3) – $225.64 (Jun 16) |
| Market Cap | ~$2.14T |
| P/E / Dividend | N/A (EPS -$1.10) / None |
| Volume vs. Average | 93.0M vs. ~93.7M |
| Analyst View | Range from Moffett Hold $142 to Morgan Stanley Buy $300; Barclays Overweight $254 (initiated Oct 8) |
| Support 1 / 2 / 3 | $160.57 / ~$155 / $135 (IPO price) |
| Resistance 1 / 2 / 3 | $166.38 / ~$175 / $225.64 |
| Next Earnings | Estimated November 3 |
Catalyst & Latest News: SpaceX agreed to buy up to 14 MHz of paired 800 MHz spectrum from Grain Management, pending FCC approval. The FCC also authorized a 15,000-satellite direct-to-cell network.
Technicals: SPCX has held the $160 area through the shock. It listed at $135 on June 12 and fell about 50% from its post-IPO peak by late July, per Wikipedia’s IPO summary.
Fundamentals: Price-to-sales is above 75x and the company is loss-making.
Bull Case: A real mobile network narrative and a wave of Buy initiations. Bear Case: A trillion-dollar valuation, heavy capital needs for ground towers and FCC risk.
What to Watch:
- A hold above $160.57
- FCC filings and tower-lease news
- More analyst initiations
Forecast: A close above $166.38 opens $175. A break under $160.57 targets $155.
Why This Matters: SPCX is the catalyst behind five of the ten moves in this list.
5. AST SpaceMobile (ASTS) | Last Close $50.97 (-10.48%) | A Fresh 52-Week Low
Down 63% From Its Peak as SpaceX Closes the Low-Band Door
ASTS closed at $50.97, down 10.48%, after touching a 52-week low of $47.57. Volume reached about 53.8 million shares against a 12.9 million average.
| Metric | Value |
|---|---|
| Last Close | $50.97 (after-hours $50.93) |
| Previous Close | ~$56.94 (Oct 8) |
| Day’s Move | -10.48% (-$5.97) |
| Day’s Range | $47.57 – ~$52 |
| 52-Week Range | $47.57 – $133.86 (May 28) |
| Market Cap | ~$19.8B |
| P/E / Dividend | N/A / None |
| Volume vs. Average | ~53.8M vs. 12.9M (~4.2x) |
| 1-Year Trend | About -39% |
| Analyst View | B. Riley Neutral, $65; Cantor Overweight, $90 |
| Support 1 / 2 / 3 | $47.57 / ~$45 / ~$40 |
| Resistance 1 / 2 / 3 | ~$56.94 / ~$67.93 / ~$80.53 |
Catalyst & Latest News: CEO Abel Avellan said carrier partners hold about 1,000 MHz of low- and mid-band spectrum its satellites can use. Berenberg argues the deal raises ASTS’s strategic value as a partner for carriers.
Technicals: The stock is below its 20- and 200-day averages, and a death cross formed in July. Three-month volatility is about 81%. TradingKey puts Fibonacci rebound targets at $67.93 and $80.53.
Fundamentals: Satellite launch delays and competition are the key concerns.
Bull Case: Carriers may need an alternative to SpaceX, and options flow skewed bullish. Bear Case: A well-capitalized rival and a broken trend.
What to Watch:
- A hold above $47.57
- Carrier partnership news
- Launch timing
Forecast: A close above $56.94 begins a recovery toward $67.93. Under $47.57, price discovery opens.
Why This Matters: ASTS is the biggest casualty among the satellite-to-phone challengers.
6. Humana (HUM) | Last Close $431.87 (+11.6%) | A 52-Week High on Better Star Ratings
95% of Members in 4-Star Plans and a Barclays Upgrade to $515
Humana jumped 11.6% to $431.87, a 52-week high, after CMS released its 2027 Medicare Advantage Star Ratings.
| Metric | Value |
|---|---|
| Last Close | $431.87 (Oct 9) |
| Previous Close | $387.12 (Oct 8) |
| Day’s Move | +11.6% (+$44.75) |
| Day’s Range | Open $450.49; high $456.50 |
| 52-Week Range | New 52-week high |
| Market Cap | ~$51.9B |
| P/E / Dividend | ~37x–41x trailing (sources vary) / Pays a dividend |
| Volume vs. Average | Not confirmed |
| Analyst View | Barclays Overweight, $515; Cantor Overweight, $460 |
| Support 1 / 2 / 3 | ~$420 / ~$396 / $387.12 |
| Resistance 1 / 2 / 3 | ~$450 / $456.50 / $460 |
Catalyst & Latest News: Benzinga reports 95% of members are in plans rated at least four stars and 42% in plans rated 4.5 or higher. Humana reaffirmed its 2026 adjusted EPS guidance.
Technicals: A gap from $387 to $432 on a ratings catalyst. The intraday fade from $456.50 shows profit-taking.
Fundamentals: GuruFocus’ fair-value estimate is $381.40, so the stock trades about 13% above it. A four-star primary contract covers about 2.4 million members and restores quality bonus eligibility.
Bull Case: Bonus payments, margin recovery and two new Overweight ratings. Bear Case: A trailing P/E near 40x versus a five-year median near 21x, and a parabolic one-day move.
What to Watch:
- A hold above $420
- UnitedHealth’s Tuesday report as a sector read-through
- Further analyst target changes
Forecast: Holding $420 keeps $450–$460 in view. A fill toward $396 is the risk.
Why This Matters: HUM shows how much one CMS rating can reprice a managed-care stock.
7. Delta Air Lines (DAL) | Last Close Near $82 (Roughly Flat) | Fuel Bill Up $6 Billion
First EPS Miss in Two Years, Guidance Cut by 24%, and a Late Recovery
Delta reported adjusted EPS of $1.72 against estimates of about $1.75 to $1.92 and cut full-year guidance to $5.10–$5.60 from $6.50–$7.50. Shares recovered from early losses to finish roughly flat, per the Wall Street Journal.
| Metric | Value |
|---|---|
| Last Close | Near $82 (roughly flat; exact close not confirmed) |
| Previous Close | ~$82.14 (Oct 8; derived from premarket data) |
| Day’s Move | Roughly flat (premarket low -3.5% at $79.25) |
| Day’s Range | Not confirmed |
| 52-Week Range | $55.03 – $95.68 |
| Market Cap | Not confirmed |
| P/E / Dividend | ~13.4x–13.7x / Pays a dividend |
| Volume vs. Average | Not confirmed |
| YTD / 1-Year | About +15% / about +36% |
| Analyst View | Consensus FY EPS near $5.51 pre-cut |
| Support 1 / 2 / 3 | ~$79.25 / ~$75 / ~$70 |
| Resistance 1 / 2 / 3 | ~$84 / ~$88 / $95.68 |
Catalyst & Latest News: Fuel expense rose 62% to $4.14 billion. Delta now expects its annual fuel bill to rise by roughly $6 billion, about $2 billion more than it projected in July. Free cash flow guidance fell to about $2.5 billion from up to $4 billion.
Technicals: The stock defended the $79 area intraday and reclaimed the prior close, which is a constructive sign.
Fundamentals: Adjusted revenue rose 16% to $17.59 billion. Fourth-quarter EPS guidance is $1.15–$1.65 on fuel near $4.25 a gallon.
Bull Case: Strong premium demand and a market that looked through the cut. Bear Case: Oil near $90 and a guidance reset that analysts must now model.
What to Watch:
- Oil prices
- A hold above $79.25
- Read-through to other airlines
Forecast: Holding $79 keeps $84–$88 in play. Higher oil would test $75.
Why This Matters: DAL is the first earnings-season test of whether energy costs are eating consumer-facing profits.
8. Novavax (NVAX) | Last Print ~$12.69 (+15%) | Short Squeeze Ignites Again
Up 13% to 15% With Moderna, Backed by a 32% Short Float
Novavax gained 13.3% to $12.47 midday and a later quote showed about $12.69. Moderna rose 7.7% to 14.5%.
| Metric | Value |
|---|---|
| Last Verified Price | ~$12.69 (Oct 9, later quote; close not confirmed) |
| Previous Close | ~$11.02 (Oct 8; derived) |
| Day’s Move | Roughly +13% to +15% |
| Day’s Range | Not confirmed |
| 52-Week Range | $6.20 – $13.39 (as of Oct 6) |
| Market Cap | Roughly $2.0B |
| P/E / Dividend | N/A / None |
| Volume vs. Average | Not confirmed (Oct 6: 19.4M vs. ~4.8M) |
| Short Interest | ~31.8% of float (earlier data) |
| Analyst View | Buy (9 analysts); average target $14.00 |
| Support 1 / 2 / 3 | ~$11.02 / $10.88 / $10.28 |
| Resistance 1 / 2 / 3 | $13.33 / $13.39 / $14.00 |
Catalyst & Latest News: We found no Novavax-specific headline for Friday. The move came alongside Moderna and Arcturus, which suggests a vaccine-sector bid.
Technicals: NVAX is now back near its $13.39 52-week high after a pullback to $10.88 earlier in the week.
Fundamentals: Trailing revenue was about $414 million with a net loss near $248 million, per an earlier summary.
Bull Case: A heavily shorted stock at a breakout level with a $14 target. Bear Case: Headline-driven spikes have faded fast this month.
What to Watch:
- $13.39 as the breakout line
- Short-covering volume
- Sector news
Forecast: A close over $13.39 targets $14. A drop under $11 returns the range.
Why This Matters: NVAX is a squeeze candidate whose direction depends on the vaccine news tape.
9. Fastly (FSLY) | Last Print $27.86 (+10.2%) | Oppenheimer Upgrades to Outperform
A $35 Target and a Double-Digit Day for the Edge-Cloud Name
Oppenheimer’s Param Singh upgraded Fastly to Outperform with a $35 target, and shares rose 10.2% to $27.86.
| Metric | Value |
|---|---|
| Last Verified Price | $27.86 (Oct 9 morning; close not confirmed) |
| Previous Close | ~$25.28 (Oct 8; derived) |
| Day’s Move | +10.2% |
| Day’s Range | Not confirmed |
| 52-Week Range | Not confirmed |
| Market Cap | Not confirmed |
| P/E / Dividend | Not confirmed / None |
| Volume vs. Average | Not confirmed |
| Analyst View | Oppenheimer Outperform, $35 (about +26% from $27.86) |
| Support 1 / 2 / 3 | ~$25.28 / ~$24 / ~$22 |
| Resistance 1 / 2 / 3 | ~$30 / ~$32 / $35 |
Catalyst & Latest News: The Oppenheimer upgrade was the only Fastly-specific headline we confirmed.
Technicals: The gap from $25 to $28 is the key support. Levels above are round-number zones, not sourced prices.
Fundamentals: We could not confirm current revenue or valuation figures for this piece.
Bull Case: An upgrade with a clear target. Bear Case: A one-day pop without a company catalyst.
What to Watch:
- A hold above $25.28
- Follow-on analyst notes
- Earnings date announcement
Forecast: Holding the gap targets $30. A fill toward $25 would cancel the upgrade pop.
Why This Matters: FSLY is an upgrade-driven mover where the first pullback shows the real demand.
10. Evolution Metals & Technologies (EMAT) | Last Print $1.94 (+13.8%) | Guidance Raised 62%
A $400–$460 Million 2027 Outlook From a $10 Million 2026 Base
EMAT raised fiscal 2026 revenue guidance to $10–$11 million from $5–$8 million and reaffirmed a $400–$460 million fiscal 2027 outlook.
| Metric | Value |
|---|---|
| Last Verified Price | $1.94 (Oct 9 morning; close not confirmed) |
| Previous Close | ~$1.70 (Oct 8; derived) |
| Day’s Move | +13.8% |
| Day’s Range | Not confirmed |
| 52-Week Range | Not confirmed (earlier 2026 data showed $7.05–$24.37) |
| Market Cap | Not confirmed |
| P/E / Dividend | N/A (loss-making) / None |
| Volume vs. Average | Not confirmed |
| Analyst View | No coverage located |
| Support 1 / 2 / 3 | ~$1.70 / ~$1.50 / ~$1.25 |
| Resistance 1 / 2 / 3 | ~$2.00 / ~$2.50 / ~$3.00 |
Catalyst & Latest News: Thirteen additional ULVAC magnet machines are scheduled for October delivery at its Pohang, Korea site, expanding capacity to more than 10,000 metric tons a year. The company cites higher rare earth pricing.
Technicals: A sub-$2 stock with a headline gap. $2.00 is the psychological line.
Fundamentals: First-half 2026 revenue was only $3.5 million, so most of the new range falls in the second half. The company says its guidance rests on anticipated demand, not contracted volumes.
Bull Case: A rare-earth supply story outside China and a steep ramp plan. Bear Case: A 41x jump from 2026 to 2027 guidance rests on uncontracted demand, and an earlier price near $16 shows how far the stock has fallen.
What to Watch:
- A close above $2.00
- ULVAC delivery and installation news
- Any new customer contracts
Forecast: A close over $2.00 targets $2.50. A slip under $1.70 erases the pop.
Why This Matters: EMAT is a speculative rare-earths name where shipments, not guidance, decide the stock.
Stocks to Watch Sector Snapshot and Forecast: Telecom Shock, Towers Up, Healthcare Bid
Friday split the market cleanly: telecom carriers and satellite challengers sold off, tower owners and Humana surged, and Delta showed the cost of oil near $90. Tech steadied after Thursday’s AI sell-off. With bank earnings Tuesday and CPI Wednesday, Monday is likely to be a positioning day. Sector forecast: Expect the telecom shock to dominate early trading, with oil and rate headlines as the swing factors. For more context, see our stocks under $3 to watch on Oct 12, our NLST stock analysis Oct 2026, and our Capricor Therapeutics forecast for a biotech catalyst example.
Stocks to Watch Tomorrow At a Glance
| # | Ticker | Last Close / Print | Move | Catalyst | Key Support | Key Resistance | Bias |
|---|---|---|---|---|---|---|---|
| 1 | TMUS | $148.58 | -13.27% | SpaceX spectrum deal | ~$145 | ~$155 | Weak bounce |
| 2 | T | $22.17 | -9.81% | SpaceX spectrum deal | ~$22 | ~$23 | Breakdown |
| 3 | CCI | ~$79.64 | +15.6% | Tower-demand theory | ~$76 | ~$82 | Extended |
| 4 | SPCX | $162.57 | +1.25% | Spectrum purchase, FCC | $160.57 | $166.38 | Range hold |
| 5 | ASTS | $50.97 | -10.48% | SpaceX competition | $47.57 | ~$56.94 | 52-week low |
| 6 | HUM | $431.87 | +11.6% | Star ratings, upgrades | ~$420 | ~$450 | Extended |
| 7 | DAL | Near $82 | ~Flat | EPS miss, guidance cut | ~$79.25 | ~$84 | Fuel-sensitive |
| 8 | NVAX | ~$12.69 | ~+13–15% | Vaccine-sector bid | ~$11.02 | $13.39 | Squeeze risk |
| 9 | FSLY | $27.86 (AM) | +10.2% | Oppenheimer upgrade | ~$25.28 | ~$30 | Upgrade pop |
| 10 | EMAT | $1.94 (AM) | +13.8% | Guidance raised 62% | ~$1.70 | ~$2.00 | Speculative |
Follow TNN for daily stock market news and financial news today.
Disclaimer: This publication is entirely for informational and journalistic purposes and does not constitute formal financial, investment, or legal advice. All market investments carry inherent risks of capital loss, and small-cap, high-volatility stocks carry elevated risk. Stock prices, percentage moves, and market data cited reflect figures available at the time of publication and are subject to change as trading continues. Analyst price targets and ratings are third-party estimates and do not guarantee actual results. Always complete independent due diligence prior to executing equity trades.
About The Author
